U.S. Breast Cancer Core Needle Biopsy Market Size & Outlook
U.S. breast cancer core needle biopsy market, 2018-2030 (US$M)
Related Markets
U.S. breast cancer core needle biopsy market highlights
- The U.S. breast cancer core needle biopsy market generated a revenue of USD 347.2 million in 2023 and is expected to reach USD 481.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, ultrasound-based breast biopsy was the largest revenue generating technology in 2023.
- Other Technologies is the most lucrative technology segment registering the fastest growth during the forecast period.
Breast cancer core needle biopsy market data book summary
| Market revenue in 2023 | USD 347.2 million |
| Market revenue in 2030 | USD 481.7 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Ultrasound-based breast biopsy |
| Fastest growing segment | Other Technologies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Other Technologies |
| Key market players worldwide | Johnson & Johnson, Danaher Corp, Hologic Inc, Argon Medical Devices, Cook Medical, Becton Dickinson & Co, BD, Intact Medical, Encapsule Medical |
Other key industry trends
- In terms of revenue, U.S. accounted for 42.2% of the global breast cancer core needle biopsy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. breast cancer core needle biopsy market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 40.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Core Needle Biopsy Market Scope
Breast Cancer Core Needle Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. breast cancer core needle biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer core needle biopsy market will help companies and investors design strategic landscapes.
Ultrasound-based breast biopsy was the largest segment with a revenue share of 41.22% in 2023. Horizon Databook has segmented the U.S. breast cancer core needle biopsy market based on mri-based breast biopsy, ultrasound-based breast biopsy, mammography-based (stereotactic) breast biopsy, ct-based breast biopsy, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Breast Cancer Core Needle Biopsy Technology Outlook (Revenue, USD Million, 2018-2030)
- MRI-Based Breast Biopsy
- Ultrasound-Based Breast Biopsy
- Mammography-Based (Stereotactic) Breast Biopsy
- CT-Based Breast Biopsy
- Other Technologies
- U.S. Breast Cancer Core Needle Biopsy End use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Reasons to subscribe to U.S. breast cancer core needle biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. breast cancer core needle biopsy market databook
-
Our clientele includes a mix of breast cancer core needle biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. breast cancer core needle biopsy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. breast cancer core needle biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. breast cancer core needle biopsy market size, by technology, 2018-2030 (US$M)
U.S. Breast Cancer Core Needle Biopsy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
